InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Singh Shawn, Chairman & CEO. Insider active across 1 company, notably VistaGen Therapeutics, Inc.. In total, 10 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €101k. History available since 30 June 2021. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Singh Shawn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,541 shares@ US$1.704.5% of flowCommon StockSEC:0001415889-25-018748:0
4,854 shares@ US$2.9585.5% of flowCommon StockSEC:0001415889-24-019020:0
167 shares@ US$1.7170.1% of flowCommon StockSEC:0001415889-24-000344:0
167 shares@ US$1.58950.1% of flowCommon StockSEC:0001415889-23-010721:0
5,000 shares@ US$0.08760.2% of flowCommon StockSEC:0001415889-23-000041:0
600,000 shares@ US$0.17241.8% of flowCommon StockSEC:0001415889-22-008814:0
Canonical exit: 15 Nov 2022 (T+90)
5,000 shares@ US$0.7481.5% of flowCommon StockSEC:0001415889-22-007688:0
100,000 shares@ US$1.0040.1% of flowCommon StockSEC:0001415889-22-004988:0
3,623 shares@ US$1.65752.2% of flowCommon StockSEC:0001415889-22-000034:0
5,000 shares@ US$1.94653.4% of flowCommon StockSEC:0001415889-21-003387:0
10 of 10 declarations
About Singh Shawn
Singh Shawn is President and CEO at VistaGen Therapeutics, Inc. (XNAS). He has 10 filings in total, and across the 10 sampled filings, buys amount to EUR 101373, sells to EUR 0, over the period from 2021-07-02 to 2025-07-01, with the most frequent transaction nature shown as Attribution.
